Caladrius Biosciences, Inc. (LSTA) Tops Q3 EPS by 10c

Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q3 EPS of ($0.49), $0.10 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• SentinelOne Inc (S) PT Raised to $26 at Cantor Fitzgerald Following Strong Q2 Checks